BL-1023

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBL-1023
Drug Alias NameL-DOPA-GABA conjugate (BioLineRx)BL-1023
ClassificationBiologics
Mechanisms of ActionDopamine D1 receptor agonistsGABA receptors modulators
TargetsDopamine D1 receptorGABA receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiolinerx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolinerx Ltd
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A